Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5

Mu-Shui Dai1, Hua Lu

  • 1Department of Biochemistry and Molecular Biology, School of Medicine, Oregon Health & Science University, Portland, Oregon 97201, USA.

Insights

Ribosomal protein L5 activates the tumor suppressor p53 by inhibiting MDM2. This interaction stabilizes p53, enhances its activity, and induces cell cycle arrest, revealing a new p53 regulatory pathway.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The oncoprotein MDM2 negatively regulates the tumor suppressor p53.
  • Ribosomal proteins L11 and L23 are known to activate p53 by inhibiting MDM2.
  • The role of ribosomal protein L5 in p53 regulation was previously unclear.

Purpose of the Study:

  • To investigate the role of ribosomal protein L5 in the regulation of p53.
  • To elucidate the mechanism by which L5 affects p53 stability and activity.
  • To identify the molecular complexes involved in L5-mediated p53 activation.

Main Methods:

  • Overexpression studies in H1299 and U2OS cells to assess p53 stabilization and transcriptional activity.
  • Ubiquitination assays to evaluate the effect of L5 on MDM2-mediated p53 ubiquitination.
  • Co-immunoprecipitation experiments to identify protein complexes involving MDM2, L5, and p53.
  • Small interference RNA (siRNA) knockdown to confirm L5's role in actinomycin D-induced p53 activation.

Main Results:

  • Overexpression of L5 stabilized both ectopic and endogenous p53.
  • L5 enhanced p53 transcriptional activity, leading to p53-dependent G1 cell cycle arrest.
  • L5 inhibited MDM2-mediated p53 ubiquitination, similar to L11 and L23.
  • Actinomycin D treatment enhanced L5-MDM2 interaction, and L5 knockdown abrogated actinomycin D-induced p53 stabilization.
  • Two distinct complexes were identified: MDM2-L5-L11-L23 and p53-MDM2-L5-L11-L23.

Conclusions:

  • Ribosomal protein L5 is a novel activator of p53.
  • L5 functions by inhibiting MDM2-mediated p53 ubiquitination, thereby stabilizing p53.
  • The MDM2-L5-L11-L23 complex plays a critical role in p53 activation and tumor suppression.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.1K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
8.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K